ASIC Gazette · 15 Sep 2026 · 3 vistas
ASIC moves to deregister Trinetra Emerging Markets Growth Trust
Por FactBox Admin

The Australian Securities and Investments Commission (ASIC) has given notice that it proposes to deregister the Trinetra Emerging Markets Growth Trust (ARSN 629 674 040), a managed investment scheme, under subsection 601PB(2) of the Corporations Act 2001. The notice was published in the ASIC Gazette No. A37/26 of Tuesday 15 September 2026 and is dated 11 September 2026.
What the notice provides
Under subsection 601PB(2) of the Corporations Act 2001, ASIC may deregister the listed managed investment scheme two months after the publication of the notice, unless it is given acceptable reason not to proceed. The deregistration would remove the scheme from the register maintained by ASIC.
- Scheme name: Trinetra Emerging Markets Growth Trust
- ARSN: 629 674 040
- Effective date: two months after publication of the notice
- Condition: no acceptable reason given to ASIC not to proceed
Rights of review
Persons affected by decisions made by ASIC under the Corporations Act 2001 and other legislation it administers may have rights of review. ASIC has published Regulatory Guide 57 (Notification of rights of review, RG 57) and Information Sheet ASIC decisions – your rights (INFO 9) to help affected parties determine whether they hold such a right.
Copies of these documents are available from the ASIC Digest, the ASIC website at www.asic.gov.au, or from the Administrative Law Co-ordinator in the ASIC office with which the person has been dealing.
Impact on investors
The deregistration of the Trinetra Emerging Markets Growth Trust affects investors in the scheme, who may be impacted by the removal of the trust from the register. The two-month window provides an opportunity for affected parties to raise objections with ASIC before the deregistration takes effect.
Source: ASIC Gazette, No. A37/26, 15 September 2026, Company/scheme deregistrations, p. 19 (official reference: Corporations Act 2001, subsection 601PB(2)).